New patent for Sanofi-aventis Us drug SOLIQUA 100/33
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100/33 appeared first on DrugPatentWatch – Make Better Decisions.
The post New patent for Sanofi-aventis Us drug SOLIQUA 100/33 appeared first on DrugPatentWatch – Make Better Decisions.
The post New patent for Sanofi-aventis Us drug SOLIQUA 100/33 appeared first on Biotechblog.